Candel Therapeutics, Inc. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Exclusive License Agreement among Candel Therapeutics, PeriphaGen, and PeriphaGen Holdings (June 2023)
License Agreements
Candel Therapeutics, Inc.
Biotechnology
2023
Exclusive Patent License Agreement between The Brigham and Women's Hospital, Inc. and Advantagene, Inc.
License Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2021
Exclusive License Agreement between Advantagene, Inc. and Ventagen, LLC
License Agreements
Candel Therapeutics, Inc.
Biotechnology
NY
2021
Exclusive Patent License Agreement between The Brigham and Women's Hospital, Inc. and Advantagene, Inc.
License Agreements
Candel Therapeutics, Inc.
Biotechnology
MA
2021
Exclusive License Agreement between Advantagene, Inc. (d/b/a Candel Therapeutics), Periphagen, Inc., and Periphagen Holdings, Inc.
License Agreements
Candel Therapeutics, Inc.
Biotechnology
DE
2021
Exclusive License Agreement between Advantagene, Inc. and Ventagen, LLC
License Agreements
Candel Therapeutics, Inc.
Biotechnology
NY
2021